The Food and Drug Administration (FDA) is requiring class-wide label changes for opioid medications to provide additional information on the risks associated with long-term use.

The FDA hopes education and legal action against 7-OH products will help prevent a second opioid crisis in the US.

Republican lawmakers on the committee, who nearly unanimously voted against the measure, voiced concern about the centers’ ...

Federal officials plan to send warning letters to companies marketing products with 7-OH, part of effort to fight America's ...

The FDA is requiring opioid pain medication manufacturers to update safety labeling with a stronger emphasis on risks from long-term use, including addiction and overdose death.

Federal officials promised on Tuesday to crack down on a potent semisynthetic opioid found in gas store gummies, drinks and ...

Dr. Stephanie Stewart discusses opioid usage in Colorado, and what the treatment process looks like for patients struggling with opioid addiction.

Launched in July 2024, a north shore drug task force has seen a growing collaboration among law enforcement agencies and an ...

The U.S. Food and Drug Administration plans to require new labels on all opioid pain medications that emphasizes long-term ...

The City Council's Public Safety Committee heard about opioid trends and potential solutions to the drug crisis during a ...

A powerful new synthetic opioid, up to 1000 times stronger than morphine, has emerged in Adelaide’s street drug supply, and ...

Spokane County is moving forward with a significant expansion of its addiction and behavioral health services. The county ...